Login / Signup

Defining the Time-Limited Trial for Patients with Critical Illness: An Official American Thoracic Society Workshop Report.

Jacqueline M KruserDeepshikha Charan AshanaKatherine R CourtrightErin K KrossThanh H NevilleEileen RubinYael SchenkerDonald R SullivanJ Daryl ThorntonElizabeth M VigliantiDeena Kelly CostaClaire J CreutzfeldtMichael E DetskyHeidi EngelNeera GroverAluko A HopeJason N KatzRachel KohnAndrew G MillerMichael J NaboznyJudith E NelsonHasan ShanawaniJennifer P StevensAlison E TurnbullCurtis H WeissM Jeanne WirpsaChristopher E Cox
Published in: Annals of the American Thoracic Society (2023)
In critical care, the specific, structured approach to patient care known as a "time-limited trial" has been promoted in the literature to help patients, surrogate decision makers, and clinicians navigate consequential decisions about life-sustaining therapy in the face of uncertainty. Despite promotion of the time-limited trial approach, a lack of consensus about its definition and essential elements prevents optimal clinical use and rigorous evaluation of its impact. The objectives of this American Thoracic Society Workshop Committee were to establish a consensus definition of a time-limited trial in critical care, identify the essential elements for conducting a time-limited trial, and prioritize directions for future work. We achieved these objectives through a structured search of the literature, a modified Delphi process with 100 interdisciplinary and interprofessional stakeholders, and iterative committee discussions. We conclude that a time-limited trial for patients with critical illness is a collaborative plan among clinicians and a patient and/or their surrogate decision maker(s) to use life-sustaining therapy for a defined duration, after which the patient's response to therapy informs the decision to continue care directed towards recovery, transition to care focused exclusively on comfort, or extend the trial's duration. The plan's 16 essential elements follow four sequential phases: consider, plan, support, reassess. We acknowledge considerable gaps in evidence about the impact of time-limited trials and highlight a concern that, if inadequately implemented, time-limited trials may perpetuate unintended harm. Future work is needed to better implement this defined, specific approach to care in practice through a person-centered equity lens and to evaluate its impact on patients, surrogates, and clinicians.
Keyphrases